Ireland - English Select A Country Media Room

Helping steer students to success

AbbVie’s commitment to STEM – developing partnerships that positively influence science education


team-updated



AbbVie is committed to leveraging its expertise in the field of science and business practices to positively influence education in the communities in which it has a presence. One key objective is to help transform, promote and support STEM-related projects and activities and AbbVie actively engages with schools, colleges and industry partners to achieve this ambition.

In order to realise this objective, AbbVie recently hosted a unique STEM-focused event, in partnership with The Irish Times. It explored how Irish industry, educators, professional bodies and others stakeholders can work together to deliver optimum engagement in the STEM disciplines and help steer our students to future success.

At The Irish Times supported roundtable workshop, organisations, including Science Foundation Ireland (SFI), Engineers Ireland, BioPharmaChem Ireland, PIER, IDA and representatives of some of Ireland’s leading universities discussed the current landscape of STEM in Ireland, reviewing the challenges and opportunities that exist in this area.

AbbVie convened the event to discuss ways in which companies like it, in partnership with The Irish Times and other interested parties, can play a role in overcoming negative perceptions of STEM amongst school-goers and help Irish students better see the potential that undoubtedly exists for successful, fulfilling careers utilising these disciplines in Ireland with locally-based companies such as AbbVie.

It is important for AbbVie to be proactive in reaching out to interested parties and everyone with a stake in STEM-related initiatives to make sure that Ireland continues to be optimally positioned to be competitive as a location in all aspects of the biopharma industry.

Some of the insights, recommendations and ideas raised at this meeting are presented in our STEM Paths event video content and meeting report, both of which are available by clicking on the links to the right of your screen.

stem-group-photo

STEM Paths – Attendees at the STEM Paths event in The Irish Times were:

Back Row (from L-R): Louise Clarke, AbbVie; Dr Patricia Kieran, UCD School of Chemical and Bioprocess Engineering; John Nugent, IDA;  Dr Helena Kelly, School of Pharmacy, RCSI; Roseanne O’Leary, Engineers Ireland; Margie McCarthy, SFI; Sophie Moran, BioPharmaChem Ireland; Prof Anne Marie Healy, School of Pharmacy and Pharmaceutical Sciences, TCD; Marty Ryan, AbbVie.

Front Row (from L-R): Dr Maura Kinahan, PIER; Caroline McClafferty, AbbVie; Dick Ahlstrom, The Irish Times; Todd Manning, AbbVie; Matt Moran, BioPharmaChem Ireland 

 

representatives-stem-group

Leave abbvie.ie

The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The AbbVie Internet site that you have requested may be in a language that differs from your country of origin.

The AbbVie Internet site that you have requested may not be optimised for your screen size.

Do you wish to continue to this AbbVie site?

Exit abbvie.ie

Notice

The “Yes” link below will take you out of AbbVie family of websites.

Links which take you out of AbbVie worldwide web sites are not under the control of AbbVie, and AbbVie are not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?

Leave abbvie.co.uk

The Abbvie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Abbvie Internet site that you have requested may be in a language that differs from your country of origin.

The Abbvie Internet site that you have requested may not be optimised for your screen size.

Do you wish to continue to this Abbvie site?